The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Hegyi, P. J.,
Garami, A.,
Academia Europaea Translational Medicine Working Group:
Academia Europaea's guidelines for the visualization of clinical outcomes.
Nat. Med. [Epub ahead of print], 2025.
Péntek, I.,
Bender, T.,
Szekanecz, É.,
Gomez, I.,
Maráz, A.,
Dank, M.,
Szekanecz, Z.:
A daganatos betegek fizioterápiája: gyakorlati ajánlás háziorvosoknak.
Háziorv. továbbk. szle. 30, 56-61, 2025.
Kis, V. K.,
Schwarcz, H. P.,
Nassif, N.,
Szekanecz, Z.:
Bone mineral platelets are mesocrystals formed by monoclinic nanocrystals.
Commun Mater. 6 (1), 1-8, (article identifier: 192), 2025.
Bender, T.,
Szekanecz, É.,
Gomez, I.,
Péntek, I.,
Maráz, A.,
Dank, M.,
Szekanecz, Z.:
Daganatos betegek fizioterápiája - narratív összefoglaló és szakértői vélemény.
Magyar Onkol. 69 (1), 241-249, 2025.
Trottet, C.,
Schürch, M.,
Allam, A. A.,
Petelytska, L.,
Castellví, I.,
Becvar, R.,
de Vries-Bouwstra, J.,
Iannone, F.,
Carreira, P. E.,
Truchetet, M. E.,
Cuomo, G.,
Rezus, E.,
Cantatore, F. P.,
Simeón-Aznar, C. P.,
Parvu, M.,
Dzhus, M.,
Distler, O.,
Hoffmann-Vold, A. M.,
Krauthammer, M.,
EUSTAR:
Deep hierarchical subtyping of multi-organ systemic sclerosis trajectories: a EUSTAR study.
npj Digit. Med. 8 (1), 1-12, (article identifier: 563), 2025.
Geetha, D.,
Neumann, T.,
Karras, A.,
Cid, M. C.,
Merkel, P. A.,
Bray, S.,
Bozeman, A. M.,
Jayne, D.,
ADVOCATE Study Group:
Efficacy and safety of avacopan for treatment of patients with ANCA-associated vasculitis receiving cyclophosphamide.
RMD Open. 11 (4), 1-12, (article identifier: 005743), 2025.
Geetha, D.,
Pagnoux, C.,
Sattui, S. E.,
Merkel, P. A.,
Weiner, M.,
Draibe, J.,
Faguer, S.,
Bray, S.,
Gurlin, R. E.,
Balcells-Oliver, M.,
Bruchfeld, A.,
Jayne, D.,
ADVOCATE Study Group:
Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trial.
Rheumatology. 64 (6), 3863-3871, 2025.
Q1
Biochemistry, Genetics and Molecular Biology (miscellaneous)
(2024)
Q1
Medicine (miscellaneous)
(2024)
18.
Knox, A. V. C.,
Cominsky, L. Y.,
Sun, D.,
Cruz Cabrera, E.,
Nolan, B. E.,
Ofray, E.,
Benetti, E.,
Visconti, C.,
Barzaghi, F.,
Rosenzweig, S.,
Lawrence, M. G.,
Sullivan, K. E.,
Yoon, S.,
Rachimi, S.,
Padem, N.,
Conboy, E.,
Stojanovic, M.,
Petrovic, G.,
Pasic, S.,
Church, J. A.,
Ferdman, R. M.,
Candotti, F.,
Arlabosse, T.,
Theodoropoulou, K.,
Dutmer, C. M.,
Maródi, L.,
Szűcs, G.,
Broides, A.,
Nahum, A.,
Levy, J.,
Kettunen, K. M.,
Daddali, R.,
Seppänen, M. R. J.,
Vänttinen, M.,
Martelius, T.,
Grönholm, J.,
Peri, M.,
Azzari, C.,
Ricci, S.,
Ojaimi, S.,
Edwards, E. S. J.,
van Zelm, M. C.,
Sun, J.,
Abolhassani, H.,
Pan-Hammarström, Q.,
Hakonarson, H.,
Mayr, D.,
Boztug, K.,
Boisson, B.,
Casanova, J. L.,
Le Coz, C.,
Poon, G. M. K.,
Romberg, N.:
One hundred thirty-four germ line PU.1 variants and the agammaglobulinemic patients carrying them.
Blood. 145 (22), 2549-2560, 2025.
Mongin, D.,
Matucci-Cerinic, M.,
Walker, U.,
Distler, O.,
Becvar, R.,
Siegert, E.,
Ananyeva, L. P.,
Smith, V.,
Alegre-Sancho, J. J.,
Yavuz, S.,
Limonta, M.,
Riemekasten, G.,
Rezus, E.,
Vonk, M. C.,
Truchetet, M. E.,
del Galdo, F.,
Courvoisier, D. S.,
Iudici, M.,
EUSTAR:
Oral glucocorticoids for skin fibrosis in early diffuse systemic sclerosis: a target trial emulation study from the European Scleroderma Trials and Research group database.
Arthritis Care Res. 77 (5), 649-657, 2025.
Sebbag, E.,
Molina-Collada, J.,
Ndoye, R.,
Aletaha, D.,
Askling, J.,
Gente, K.,
Bertheussen, H.,
Bitoun, S.,
Bolek, E. C.,
Buch, M. H.,
Burmester, G. R.,
Canhão, H. M.,
Chatzidionysiou, K.,
Curtis, J. R.,
Danlos, F. X.,
Guimarães, V.,
Hetland, M. L.,
Iannone, F.,
Kostine, M.,
Kragstrup, T. W.,
Kvien, T. K.,
Regierer, A. C.,
Schulze-Koops, H.,
Sedmak, N.,
Silva-Fernández, L.,
Szekanecz, Z.,
Lauper, K.,
Finckh, A.,
Gottenberg, J. E.:
Systematic literature review and meta-analysis informing the EULAR Points to Consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Ann. Rheum. Dis. 84 (4), 643-652, 2025.
D1
Biochemistry, Genetics and Molecular Biology (miscellaneous)
(2024)
D1
Immunology
(2024)
D1
Immunology and Allergy
(2024)
D1
Rheumatology
(2024)
21.
Courel-Ibáñez, J.,
Prieto-Moreno, R.,
Briones-Vozmediano, E.,
Ariza-Vega, P.,
Angevare, S.,
Antón, J.,
Bini, I.,
Clemente, D.,
Correia, M.,
Costello, W.,
De Cock, D.,
Domján, A.,
Leon, L.,
Marques, A.,
Minden, K.,
Mourão, A. F.,
Najm, A.,
Özen, S.,
Pimentel, G.,
Saleem, Z.,
Vetrovsky, T.,
Wulffraat, N. M.,
Zacarias, A.,
Prior, Y.,
Carmona, L.,
Estévez-López, F.:
Systematic literature review informing the EULAR points to consider for patient education in physical activity and self-management of pain during transitional care.
Ann. Rheum. Dis. [Epub ahead of print], 2025.